RayzeBio is focused on creating precision radiopharmaceutical therapies (RPTs) that transform people’s lives
RayzeBio is focused on creating precision radiopharmaceutical therapies (RPTs) that transform people’s lives. With an innovation-leading position in actinium-based RPTs and a pipeline of potentially first-in-class and best-in-class drug development programs, RayzeBio is at the forefront of pioneering the application of the next wave in cancer treatment.